WST: West Pharma Company Value to Net Income

West Pharma Corp - graphic logo of issuer WST

West Pharmaceutical Services generates revenue by supplying injection components, capitalizing on the demand for GLP-1 drugs. The company's P/E valuation profile illustrates multiplier dynamics, where the value of 46.00 characterizes this level. Risks are associated with a potential shift by pharma behemoths toward needle-free methods. A high dependence on FDA certification solidifies the business's dominant position within its niche.

West Pharma (WST) Price to Earnings Ratio: for the period 07/04/2022 - 11/16/2026

Analytical breakdowns for West Pharmaceutical Services Inc (WST)

- market capitalization information:
Comprehensive company analysis:West Pharmaceutical Services Inc - WST
Manufactured product of West Pharma

Analyzing the West Pharmaceutical Services (WST) business model through the P/E ratio history allows for an assessment of the company's market value relative to its net income. This indicator measures the investment payback period, reflecting market expectations for future cash flows. Mathematically, the metric correlates total capitalization with annual income, demonstrating a premium for the uniqueness of the sealing ecosystem. The heavy reliance of pharma behemoths on FDA certification makes this multiple resilient to competition.

Competing companies

P/E Multiple Intuitive Surgical, Inc.|Price to Earnings Ratio DHR (Danaher Corp)|BDX (Becton, Dickinson and Company) - Company Value to Net Income|P/E Multiple STE (steris.com)|Business Payback Period baxter.com (BAX)|Masimo Corp - P/E Multiple|Business Payback Period Stevanato Group SpA STVN|Teleflex Corp (TFX) - Price to Earnings Ratio|Price to Earnings Multiple MMSI|Price to Earnings Ratio envistaco.com|ICU Medical (ICUI) - Business Payback Period|Price to Earnings Ratio XRAY (DENTSPLY SIRONA Inc.)|Market Price to Net Income Ratio LMAT|Price to Earnings Ratio AtriCure Corp ATRC|Company Value to Net Income STAA|NAGE: Price to Earnings Ratio|ZIMV - P/E Multiple|AngioDynamics Inc (ANGO) - Price to Earnings Ratio|Price to Earnings Ratio Cerus|TKNO (teknova.com) - P/E Multiple|Market Cap to Earnings Monogram Orthopedics Inc. MGRM|Price to Earnings Ratio Sharps Tech (STSS)|InfuSystem Inc - Price to Earnings Multiple|Utah Medical Products - Price to Earnings Ratio|Market Price to Net Income Ratio KRMD (KORU Medical Systems)|NYXH - Price to Earnings Ratio|Business Payback Period Microbot Medical, Inc MBOT|Pro-Dex Corp (PDEX) - Price to Earnings Ratio|Market Cap to Net Income ZTEK (Zentek Ltd.)|Price to Earnings Ratio Elutia|Milestone Scientific Inc (MLSS) - Business Payback Period|Price to Earnings Ratio NXGL (NEXGEL, Inc.)|RVP (Retractable Technologies, Inc.) - Company Value to Net Income|Harvard Bioscience, Inc. - Price to Earnings Ratio|P/E Multiple femasys.com FEMY|MHUA: Price to Earnings Ratio|Business Payback Period predictive-oncology.com POAI|Callan JMB Inc (CJMB) - Price to Earnings Ratio|Price to Earnings Multiple ATRI|NURO (NeuroMetrix Inc) - P/E Multiple